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Abstract
With the aim of improving the compatibility of biomaterials to be used for the construction of cardiovascular prosthesis, we have
designed bioactive macromolecules resulting from chemical modifications of hyaluronic acid (Hyal). The stability constants of Cu(II) and
Zn(II) complexes with the sulphated derivative of hyaluronic acid (HyalS ) were evaluated. Two different complexes have been found3.5
for each metal ion, CuL, Cu(OH) L and ZnL, Zn(OH) L (L means the disaccharide unit of the ligands) in aqueous solution at 378C. The2 2
dihydroxo Cu(II) complex was present in high percentage at pH57.4. On the contrary, the Zn(II) ion was present with a relatively low
percentage of both complexes. The ability to stimulate endothelial cell adhesion and migration was evaluated for Hyal, HyalS and their3.5(4.5)2
complexes with Cu(II) and Zn(II) ions. The results revealed that Hyal and [Cu(OH) HyalS ] induced cell adhesion, while2 3.5(2.5)2 (4.5)2[ZnHyalS ] and [Zn(OH) HyalS ] inhibited the process. The chemotactic activity of increasing concentrations of the above3.5 2 3.5 (4.5)2
complexes was also evaluated, demonstrating that [Cu(OH) HyalS ] complex at 1 mM concentration was the most active in2 3.5
inducing cell migration. These results have been also strengthened by analysing adherent cell migration in agarose. In conclusion,
sulphated hyaluronic acid coordinated to Cu(II) seems to be a promising matrix molecule for the construction of cardiovascular prosthesis.
Ó 2000 Elsevier Science S.A. All rights reserved.
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1. Introduction confers a major stability to hyaluronic acid, leading to an
increased half-life [3]. The design of new anticoagulant
In recent years a big effort has been made to improve molecules which can replace heparin is of extreme impor-
the cellular compatibility of biomaterials to be used for the tance to avoid the complications due to continuous ad-
construction of cardiovascular, orthopedic, plastic and juvant therapy and to produce novel blood compatible
reconstructive surgery prosthesis. Recently our group has materials to be linked to the surface of medical devices.
actively been involved in the demonstration that some One of the events relevant for the reduction of xenograft
chemical modifications of polysaccharides are able to rejection in humans is the cellular biocompatibility of the
change their biological activity. Sulphation of hyaluronic matrix. Specifically, in the case of cardiovascular pros-
acid (Hyal) [1] allows for the acquisition of a biological thesis the adhesion, attachment and spreading of vascular
activity (inhibition of platelet aggregation, anticoagulant endothelial cells on the biomaterial are necessary, along
activity and increased endothelial cell proliferation rate) in with the absence of procoagulant activity. Many are the
comparison with the native molecule, leading to a potential growth and adhesion factors able to stimulate endothelial
endothelium-dependent action [2–4]. Moreover sulphation cell adhesion, movement and proliferation. A great number
of vascular endothelial growth factors are polypeptides
(i.e. vascular endothelial growth factors, fibroblast growth*Corresponding author. Tel. / fax: 139-577-232-033.
E-mail address: barbucci@unisi.it (R. Barbucci). factors, angiopoietins, interleukin-8, transforming growth
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factor, tumor necrosis factor), or to a less extent lipid
molecules (prostaglandin E1, platelet-activating factor) [5–
7]. A pivotal role is played by extracellular matrix
components such as collagen, fibronectin and heparan
sulphates. Heparin, and generally proteoglycans, play an
important role in angiogenesis and vascularization, being
low affinity receptors for angiogenic inducers such as basic
fibroblast growth factor, vascular endothelial growth fac- Scheme 1. Disaccharide unit of hyaluronic acid.
tor–A and transforming growth factor-beta [8–11] and
modulating endothelial cell adhesion and migration
[12,13]. We have recently shown that hyaluronic acid can easily
Other components important for endothelial cell func- be sulphated and molecules with a certain number of
tions are oligoelements and metals such as copper and sulphates per repeating unit (disaccharide unit) can be
2
zinc. They are essential constituents of macromolecules as obtained ranging from 1 to 4 OSO groups. The most3
enzymes, soluble proteins and matrix components. They sulphated terms of the series, i.e. HyalS and HyalS ,3.5 4.0
play an important role both for the conformation and the show quite good anticoagulant activities [2]. The precise
catalytic activity of the macromolecules. Micromolar con- structure of hyaluronic acid allowed us to study the
centrations of copper induce endothelial cell migration [14] protonation behaviour in aqueous solution by a thermo-
and proliferation [15] by unknown mechanisms that could dynamic point of view, as well as the ability to form
require the ion binding to fibroblast growth factor receptors complexes with Cu(II) and Zn(II) ions (Scheme 1).
[16] or to angiogenin [17]. It has been also observed that The aim of the present study was to evaluate the
the accumulation of copper preceded the rabbit cornea stability and the biological activity of hyaluronic acid
vascularization induced by implanted tumor cells [18] and complexes with Cu(II) and Zn(II) ions and its sulphated
that chelation of copper ions inhibits the angiogenesis derivative and to assess the effect of Cu(II)-HyalS and3.5
associated with the growth of a experimental gliosarcoma Zn(II)-HyalS complexes present at physiological pH on3.5
in rats [19]. Furthermore, copper as salt [20] or coordi- cultured endothelial cells. The studies were integrated with
nated with some biological molecules, such as cerulo- analogous tests performed on Cu(II), Zn(II) complexes
plasmin, is an angiogenic inducer [14,21,22]. Actually, with non sulphated Hyal. The protonation and Cu(II),
heparin-copper (II) complex is an efficient angiogenic Zn(II) stability constants were determined at 378C to
factor in rabbit cornea and induces the in vitro migration of identify the stoichiometry of the complexes and their
capillary endothelial cells [23,14,18]. Zinc is another percentage at body temperature. Endothelial cell fuctions
element which modulates some endothelial cell functions relevant for the biocompatibility of the materials under
related to angiogenesis. It is an essential component of study (i.e. adhesion and migration) were studied.
metalloproteinases, key enzymes involved in endothelial
cell invasiveness during the early stages of angiogenesis.
When used as soluble form, zinc stimulates the prolifer- 2. Materials and methods
ation of endothelial cells [24] and promotes the repair of
wounded monolayers of this cell type [25]. 2.1. Reagents
On this basis, the development of macromolecules
coordinated to metal ions seems promising for the develop- Sulphated hyaluronic acid samples, with 3.5 sulphate
ment of matrix for improving endothelial cell biocom- groups per disaccharide unit (HyalS ), were obtained as3.5
patibility and reducing blood clotting in vivo. However, previously reported [1,29] and determined by C, H, N, S,
heparin is not entirely understood from the chemical point elemental analysis. Hyaluronic acid (M.W.5180 000) was
of view, and due to its variety, it is still difficult to define kindly provided by FAB (Fidia Advanced Biopolymers-
the stoichiometry of the metal ion complex. Some authors Padova, Italy).
have found the N-sulphate, O-sulphate and the carboxyl
groups are involved in the Cu(II) binding process [26,27], 2.2. Potentiometric measurements
whereas our group ascertained the presence of only
carboxyl and acetyl groups in Cu(II) binding [1]. By using 2.2.1. Protonation studies
low molecular weight saccharide molecules, it has been Potentiometric titrations were performed according to a
reported that the heparin cell-modulating activities depend previously described procedure [30]. A Crison MicropH-
primarily on a minimum intramolecular density of neigh- 2002 potentiometer, equipped with a combined electrode
bouring anionic groups (sulphate) [28]. All these activities (Crison mod. 6.0204.000) was used together with an
are associated with the multi-ionic complex formation automatic Crison microburette (mod. 2031) connected to a
between the clusters of anionic and cationic sites on the PC 386 DX 40 MHz. For each titration experiment, the
complexing molecules. cell was filled with ca. 20–25 ml of 0.1 M NaCl solution
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in which a known amount of solid polymer was dissolved isolated from umbilical veins by collagenase digestion
by magnetic stirring under nitrogen stream. The titration following a standard protocol [33]. Cells were maintained
data were automatically stored on a floppy disk for further in a 5% CO atmosphere at 378C in medium 199 (Sigma,2
processing. The basicity constants were computed by the Italy) with 20% FCS, L-glutamine and gentamicin. Cells
HYPERQUAD package program [31] on the 386 DX 40 were identified as endothelial by their polygonal morpholo-
MHZ computer, once it was ascertained that the basicity gy. For migration experiments cells were used when
2
constant of the COO of the repeating unit does not cultures had reached confluence.
depend on the protonation degree of the whole macro-
molecules [32]. 2.4. Adhesion assay
2.2.2. Zn(II) and Cu(II) complex-formation To assess the ability of test substances to interfere with
The potentiometric titrations were carried out at 378C by cell adhesion, endothelial cells were let to adhere to
the same potentiometric apparatus described above. The polystyrene plastic wells in the presence of test substances.
stability constants of the Cu(II)-polymer and Zn(II)-poly- Elisa 96-multiwell plates were coated with 10 mg/ml
mer complexes were determined by adding standard fibronectin. Cells were detached from confluent cultures
4
sodium hydroxide solution to a solution containing the and suspended at the density of 5310 /ml. 100 ml of cell
polysaccharide and the metal ion. Computation of the suspension in the presence of test substances were put in
21
stability constants was performed by the HYPERQUAD each well and incubated at 378C for 30 min h. Cells
program [31]. were washed with PBS and then fixed in methanol and
The experimental details for the potentiometric titrations stained in Diff-Quick (Harleco, Gibbstown, NJ, USA).
are summarised in Table 1. Adherent cells were counted at 1003 magnification with
2the aid of an ocular grid (21 mm ) [38]. Data are
2.3. Cell culture expressed as total cell number counted /well.
H.end.FB cell line was obtained from heart cells taken 2.5. Motility assays
thfrom a mouse fetus DBA/2Xc57b1/6 at the 13 day of
gestation and immortalised by infection with N-TKmT 2.5.1. Chemotaxis assay
retroviral vector containing mT antigen of polyoma virus Chemotaxis experiments were performed with the
[33–35]. This cell line was characterised as endothelial on Boyden chamber technique (48-well microchemotaxis
the basis of CD31, VE-cadherin and factor VIII expression, chamber) using polycarbonate filters (5 mm pore size,
uptake of low density acetylated lipoproteins, synthesis of polyvinylpyrrolidone-free, Nucleopore Costar Italia,
platelet activating factor and monocyte chemotactic Milano,Italy) [16–18]. Three different concentrations of
peptide-1 after stimulation with interleukin-1 and tumor Hyal, HyalS , Cu(II)-Hyal, Zn(II)-Hyal, Cu(II)-HyalS ,3.5 3.5
necrosis factor [36,37]. H.end.FB cells were kept in Zn(II)-HyalS , CuCl and ZnCl (0.1, 1 and 10 mM) in3.5 2 2
DMEM (Dulbecco’s Modified Eagle Medium, Gibco- 2% FCS-DMEM were placed in the lower compartment of
5Europe Paisley, Scotland) supplemented wih 10% fetal the chamber, and 1310 cells suspended in DMEM
bovine serum (FCS) (Sigma Chemical Co., St. Louis, containing 2% FCS were put in the upper compartments.
MO). After 6 h of incubation at 378C, the upper surface of the
Human umbilical vein endothelial cells (HUVEC) were filter was scratched in order to remove non-migrated cells.
Table 1
Experimental details for the protonation and complex-formation potentiometric measurements at 378C in NaCl 0.1 M
a a aCompound System T , mmol T , mmol added HCl C , mM Range of pHL M T
mmol
(4.5)2 1HyalS H 1L 0.03552 – 0.09110 0.0993 2.5–10.83.5
0.03547 – 0.08733 0.0993 2.5–10.5
21Cu 1L 0.03134 0.02846 0.09534 0.1000 2.5–10.8
0.03066 0.00605 0.08364 0.1000 2.7–10.9
0.03152 0.00608 0.08419 0.1000 2.6–11.3
0.03115 0.00616 0.08096 0.1000 2.6–11.3
21 4.52Zn 1L 0.02660 0.01330 0.12769 0.0998 2.4210.6
21Zn 1L 0.02491 0.01245 0.11306 0.0998 2.4210.8
0.02660 0.00532 0.13103 0.0998 2.4211.0
0.02696 0.00539 0.13089 0.0998 2.4210.9
0.02600 0.02340 0.12388 0.0998 2.4210.8
0.02708 0.02708 0.12273 0.0998 2.4210.8
a T : initial amount of the ligand; T : initial amount of metal ion; C : concentration of titrating solution (NaOH).L M T
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Filters were fixed and stained with Diff-Quick. The directed toward one side; 3, 95–100% of the cells directed
number of cells present in five oil immersion fields /well toward one side.
was counted at 1003 magnification. DMEM containing
2% FCS was used as negative control and complete M199 2.6. Statistical analysis
containing 10% FCS as positive control.
Analysis of variance (ANOVA) was applied to the data2.5.2. Migration assay for cell adhesion and motility; P values ,0.05 wereThe migration tests were performed on agarose gels as
considered statistically different. Post hoc comparisonspreviously described [23]. Briefly, tissue culture dishes between groups (95% confidence for mean) were carried
were coated with gelatin and agarose solution was poured
out by a least squares difference test (LSD test) when
on the gelatin and allowed to harden at room temperature.
appropriate.Then, three wells were cut with a suitable template.
Endothelial cells were seeded into the central well and
dishes were incubated for 5 h (378C, 5% CO ) to allow2
3. Resultsattachment. The sample test solution was put into one well
while the sample control solution in the controlateral well.
3.1. Protonation constant and Cu(II) and Zn(II) stabilityThe samples containing Hyal /Cu(II) and Cu(II)-HyalS3.5
constantswere dissolved in phosphate buffered saline (PBS) solu-
tion. The sample containing CuCl 2H O salt was dissolved2 2
2The protonation constant relative to the COO group ofin Tris solution. The molar ratio of Cu(II)-Hyal and
the disaccharide unit of hyaluronic acid derivative HyalSHyalS /Cu(II) was nearly 1. All the solutions were 3.53.5
at 378C (log K 3.99) was very close to the analogoussterilised by filtering with 0.2 mm filters. Incubation (378C,
constant determined at 258C (log R53.94) [39]. Thus, the5% CO ) followed for 12 h. Cells were then fixed and2
2protonation reaction of the COO group in this moleculestained with Diff-Quick. Cell migration toward the stimuli
was almost athermic, not being influenced by the tempera-was quantified microscopically at a magnification of 403
ture. The Cu(II) complex species found at 378C were thein a blind manner by two independent operators. Cell
52
same ones previously seen at 258C for HyalS [27], i.e.migration was quantified by using the following score: 0, 4(2.5)2the simple [CuHyalS ] complex and the dihydroxono directional movement; 1, at least 10% of the cells 3.5
(4.5)-directed toward one side; 2, at least 50% of the cells [Cu(OH) HyalS ] complex (Fig. 1). Zn(II) ion with2 3.5
Fig. 1. Cu(II)-HyalS complex: Potentiometric titration curve and distribution curves of the species in solution at different pH’s at 378C in 0.1 M NaCl;3.5
4.52 2.52 3.52 4.52 4.52A5L ; B5CuL ; C5LH ; D5Cu(OH) L ; [L5HyalS ].2 3.5
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Fig. 2. Zn(II)-HyalS complex: Potentiometric titration curve and distribution curves of the species in solution at different pH’s at 378C in 0.1 M NaCl;3.5
4.52 2.52 3.52 4.52 4.52A5L ; B5ZnL ; C5LH ; D5Zn(OH) L ; [L5HyalS ].2 3.5
(2.5)2HyalS formed two complexes [ZnHyalS ] and 3.2. Adhesion of endothelial cells in the presence of3.5 3.5(4.5)2[Zn(OH) HyalS ] at 378C (Fig. 2), the same species Hyal and HyalS , and their complexes with Cu(II) and2 3.5 3.5
found with Cu(II), but not exactly the same found with Zn(II) ions
52Zn(II) ion and HyalS at 258C, where only the dihydroxo4
complex was present [39]. Cellular adhesion is one of the early events during the
Knowing the stability constants at 378C, the percentage attachment of endothelial cells to the extracellular matrix.
of the complex species at physiological pH (7.4) could be The number of cells adhered to polystyrene plates coated
calculated (Table 2). The dihydroxo Cu(II) complex was with fibronectin was evaluated after 30 min of stimulation
present in a very high percentage (90%); thus this com- of endothelial cells in suspension with the different
pound could be considered responsible for any of the compounds at 1 mM concentration. Two-way ANOVA
biological effects. On the contrary, Zn(II) ion at pH57.4 showed significant differences among the basal and Hyal,
was present with a relatively low percentage of both Cu(II)-HyalS and Zn(II)-HyalS (Fig. 3). Specifically,3.5 3.5(2.5)2
complexes, 33% [ZnHyalS ] and 26% as the compounds most effective in inducing endothelial cell3.5(4.5)2[Zn(OH) HyalS ] . adhesion were Hyal (P,0.05) and2 3.5
Table 2
(4.5)2 21 21 aStability constants of the sulphated hyaluronic acid (HyalS ) with Cu and Zn at 378C in 0.1 M NaCl3.5
bReaction Log b* % species at 378C and pH57.4
(2.5)2 (4.5)2 (4.5)2ML M(OH) L L2
21 (4–5)2 (2.5)2Cu 1HyalS á[Cu HyalS ] 3.58(1) 0 90 103.5 3.5
21 (4–5)2 2 (4.5)2Cu 1HyalS 12OH á[Cu(OH) HyalS ] 17.52(2)3.5 2 3.5
21 (4–5)2 (2.5)2Zn 1HyalS á[Zn HyalS ] 3.37(2) 31 26 413.5 3.5
21 (4–5)2 2 (4.5)2Zn 1HyalS 12OH á[Zn(OH) HyalS ] 15.17(2)3.5 2 3.5
a 21 21The potentiometric titration were carried out at 378C. The stability constants of the Cu polymer and Zn polymer complexes were determined by
adding standard sodium hydroxide solution to solution containing the polysaccharide and the metal ion at pH57.4.The values of the stability constants are
expressed as mean1S.D. *Values in parentheses are standard deviation.
b (4.5)2 21 21 (4.5)2 1 (3.5)2L5HyalS ; M5Cu or Zn ; Log K (HyalS 1H HyalS H )53.99(1).3.5 3.5 3.5
234 R. Barbucci et al. / Journal of Inorganic Biochemistry 81 (2000) 229 –237
Fig. 3. Adhesion of endothelial cells in the presence of 1 mM CuCl , ZnCl , Hyal, HyalS , Cu(II)-Hyal, Zn(II)-Hyal, Cu(II)-HyalS and2 2 3.5 3.5
Zn(II)-HyalS . H.end.FB cells were let to adhere to polystyrene plates coated with 10 mg/ml fibronectin in the presence of test substances for 30 min.3.5
Data are expressed as adherent cells counted in six random fields /well. Numbers represent mean6S.E. (n53); *P,0.05 vs. basal condition.
(4.5)2[Cu(OH) HyalS ] (P,0.05). On the contrary, the2 3.5
Zn(II)-HyalS complexes were the most effective in3.5
inhibiting cell adhesion (P,0.05). All the other com-
pounds stimulated cell adhesion without any significant
differences when compared to basal condition.
Furthermore, after 1 h a complete adhesion of endotheli-
al cells was observed in all the wells with no difference
among the tested compounds (data not shown).
3.3. Chemotactic activity by Hyal and HyalS3.5
complexes with Cu(II) and Zn(II) ions
Cell migration is another early function of endothelial
cells during vascularization. Chemotaxis of endothelial
cells in suspension toward a gradient of stimuli can be
studied in vitro by the Boyden Chamber procedure.
Increasing concentrations of test substances (0.1, 1 and 10
mM) were assayed. In Fig. 4a endothelial cell migration in
response to Hyal and HyalS is reported. While Hyal did3.5
not affect endothelial cell migration at any tested con-
centration, HyalS significantly (P,0.05) increased cell3.5
chemotaxis in comparison to Hyal both at 1 and 10 mM
concentration. The effect was concentration-dependent
with maximal activity at 1 mM. A plateau phase was
observed with higher concentration (10 mM).
Endothelial cell migration was then evaluated in re-
sponse to different concentrations of Cu(II)-HyalS and3.5
(4.5)2CuCl . As evident from Fig. 4b, [Cu(OH) HyalS ]2 2 3.5
complex, even at the lowest tested concentration (0.1 mM)
(P,0.05), strongly induced cell migration. This effect was
stronger with a higher concentration (up to 1 mM, P,
0.05), which represented the maximal effective concen-
tration. Also at 10 mM cell migration induced by
(4.5)2[Cu(OH) HyalS ] complex was significantly differ-2 3.5
ent with respect to control (P,0.05). Fig. 4. Endothelial cell migration in the presence of (a) Hyal and
HyalS , (b) HyalS ,Cu(II)-HyalS and CuCl and (c) HyalS ,Zn(II)-We then assessed the chemotactic activity of increasing 3.5 3.5 3.5 2 3.5
HyalS and ZnCl . Test substances were assayed at increasing con-3.5 2concentrations of Zn(II)-HyalS and ZnCl in compari-3.5 2 centrations (0.1, 1 and 10 mM). Migration of H.end.FB cells was
son with HyalS . While ZnCl at all the three tested3.5 2 evaluated by the modified Boyden chamber technique after 6 h of
concentrations was devoid of any chemotactic effect, incubation. The number of migrated cells is expressed as mean6S.E.
Zn(II)-HyalS significantly induced cell migration (P, (n55); *P,0.05 vs. the control.3.5
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Table 40.05). Maximal effect was observed at 1 and 10 mM
aEndothelial cell migration in agarose gelconcentration (P,0.05). As shown in the distribution
System Score Systemcurves at 378C, two complexes were contemporaneously
present in solution at pH57.4 (Table 2), thus we were PBS ‹ 0fi Cu(II)
unable to determine which species induced cell migration. Cu(II)-HyalS ‹ 0.5 Cu(II)-Hyal3.5
Cu(II)-HyalS ‹ 2.5 HyalSBesides, as shown in Fig. 4c, the extent of cell migration in 3.5 3.5
athe presence of Zn(II)-HyalS might be considered HUVEC were seeded in the central well while test substances (at 13.5
mM concentration) were seeded in the lateral wells. Following 12 h ofapproximately the sum of that induced by the HyalS and3.5
incubation, cells were fixed and stained. Cell migration was quantified asby Zn(II) ion (Fig. 4c).
reported in the Material and method section. The arrow indicates theData related to the chemotactic ability of Cu(II)-Hyal direction of the cells toward the indicated stimulus. Data are representa-
and Zn(II)-Hyal demonstrated that neither of the two tive of three plates with similar results.
species seemed to be able to stimulate cell migration at the
concentrations tested (Table 3).
All these data taken together demonstrate the marked 4. Discussion
(4.5)2
chemotactic activity of [Cu(OH) HyalS ] complex2 3.5
which proves to be the most effective in inducing endo- In this study we demonstrate, for the first time, that
thelial cell chemotaxis. This effect was specific for the sulphated hyaluronic acid derivatives coordinated with
complex present in solution, since CuCl was not able to Cu(II), beside their anticoagulant and antithrombotic ac-2
induce cell migration. tivity, facilitate endothelial cell functions relevant for
vascularization as adhesion, migration and spreading.
3.4. Migration of endothelial cells toward Hyal and These characteristics are fundamental for the potential use
HyalS complexes with Cu(II) and Zn(II) metal ions of these compounds in the construction of medical devices3.5
to be used in cardiovascular surgery. Until now the major
Cell migration and spreading on extracellular matrix can problem of cardiovascular prosthesis, once implanted, has
be studied on endothelial cells by using the agarose assay. been blood clotting also due to the absence of a whole and
This test differs from the chemotaxis assay for three functioning endothelial cell monolayer in the inner surface
reasons: (i) adherent cells are used; (ii) the effect of two of the artificial graft. The criteria for the design of an
different compounds is compared in the same plate; (iii) artificial basement membrane for vascular graft must
the result of the test is the general tendency of cells to include: (1) Structural matrix, (2) enhanced adhesion and
migrate towards a gradient of the compound which dif- growth of endothelial cells and (3) ensured antithrom-
fuses through the gel. Based on chemotaxis results, in this bogenicity. Our results indicate that these criteria have all
(4.5)2 been satisfied by the Cu(II)-coordinated to suphated hy-assay the motogenic effect of [Cu(OH) HyalS ] was2 3.5
aluronic acid.compared to the activity elicited by HyalS and Cu(II)-3.5
The use of hyaluronic acid in reconstructive surgery hasHyal complex. The results obtained showed that
(4.5)2
already been reported. Non-modified hyaluronic acid has[Cu(OH) HyalS ] was more powerful than HyalS2 3.5 3.5
been used for the development of artificial skin materialand Cu(II)-Hyal complex in inducing cell migration,
and has been demonstrated to accelerate granulation tissuewhereas Cu(II) was devoid of any migratory activity
ingrowth and to increase the number of capillaries present(Table 4). These observations confirm the results obtained
in the matrix [40].in the chemotaxis assay, underlining the high ability of
(4.5)2 Copper and zinc are two metal ions which activate in[Cu(OH) HyalS ] in stimulating cell migration.2 3.5
vitro a pro-angiogenic program in vascular endothelial
cells (i.e. migration and proliferation) [7–15,24,25]. Cop-Table 3
per as salt or coordinated to proteins or proteoglycans isEndothelial cell migration in the presence of Zn(II)-Hyal and Cu(II)-
aHyal also angiogenic in vivo [7,20–22]. The results presented
here identify another class of compounds, i.e. the sulphatedSamples Number of
hyalurane derivatives which, once coordinated to Cu(II)migrated cells
ion, are able to induce cell migration. The first chemicallyControl 30.363.4
defined complex species between HyalS and Cu(II), i.e.Zn(II)-Hyal 0.1 mM 31.062.8 3.5(4.5)2Zn(II)-Hyal 1 mM 33.763.1 [Cu(OH) HyalS ] , is able to activate adhesion of2 3.5
Zn(II)-Hyal 10 mM 31.764.2 endothelial cells to fibronectin as well as their migration.
Cu(II)-Hyal 0.1 mM 29.761.9 Furthermore we have found evidence that the systemCu(II)-Hyal 1 mM 32.763.3 Zn(II) and HyalS slacken the adhesion and do not3.5Cu(II)-Hyal 10 mM 28.362.1
promote the migration of endothelial cells. In solution at
a Test substances were assayed at increasing concentrations (0.1, 1 and pH57.4 Zn(II) is present with two complexes:10 mM). Migration of H.end.FB cells was evaluated by the modified (2.5)2 (4.5)2[ZnHyalS ] and [Zn(OH) HyalS ] . Thus weBoyden chamber technique after 6 h of incubation. The number of 3.5 2 3.5
migrated cells is expressed as mean6S.E. (n55). are unsure which complex species is responsible for the
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biological effect found. Furthermore, while the stability ever, a complete assessment of biocompatibility of these
constant of the dihydroxo complex species is high enough biomaterials on vascular endothelial cells both in vitro and
to presume that it is present in solution even with the in vivo is still absent.
contemporaneous presence of other competitive ligands
such as aminoacids, proteins etc. of the medium, the
simple complex shows a very low stability which does not Acknowledgements
assure its presence in the medium. In conclusion, with
Zn(II) we also attribute the biological effects to the The authors would like to thank Progetto Finalizzato
dihydroxo complex species even if present in low per- MSTA II of the National Research Council and Italian
(4.5)2
centage in solution. [Cu(OH) HyalS ] , which pre- Association for Cancer Research (AIRC) for financial2 3.5
sents a precise structure in solution [29], is the first defined support.
coordination complex between copper and a polysac-
charide eliciting a biological response on endothelial cells.
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